GVR Report cover Custom Antibody Market Size, Share & Trends Report

Custom Antibody Market Size, Share & Trends Analysis Report By Type, By Service, By Source, By Application, By End-user, By Region, And Segment Forecasts, 2022 To 2030

  • Report ID: GVR453488
  • Number of Pages: 0
  • Format: Electronic (PDF)

A custom antibody is designed or produced by the supplier for a specific antigen with the help of 90% purified antigen. Polyclonal and monoclonal antibodies are produced using custom antibody production. The steps of custom polyclonal antibody production are peptide design, designing of peptides, animal immunization, serum collection, titer analysis, and antibody purification. The steps for custom monoclonal antibody production are antigen preparation, immunizations of hybridoma development, hybridoma development fusions, monoclonal production and purification. The custom antibody has better selectivity compared to the normal cultured antibodies.

Custom Abs have a wide range of applications in treating asthma, autoimmune diseases, cancer, poisoning, septicemia, viral infection, and other diseases. The prevalence of these diseases is increasing globally which boosts the market. The treatment with these antibodies is cost-effective. So hospitals and healthcare providers have a high demand for these antibodies accelerating the market growth. Some of the successfully developed custom antibodies are proteins and mixtures, membrane proteins, peptides, methylated antigens, phosphorylated antigens, haptens and small organic molecules.

Moreover, custom antibody production services are used to create and discover new biomarkers which also has a positive impact on the growing market. The growth of personalized medicines has also increased for the treatment of cancer and other chronic diseases. This enhances the usage of custom antibodies, thus driving market growth. In June 2021, a custom rabbit mAB, MonoRab was launched by GenScript. It involves hybridoma technology and mAB sequencing. It has better specificity and better affinity applicable to a wide range of applications. The changing disease profiles, growing government funding and support, advances in biotechnology research, and rising public and private partnerships boost market growth. 

The market is segmented based on the type, service, source, application, end user, and region. The type segment is divided into monoclonal antibodies, polyclonal antibodies, and recombinant antibodies. The service segment is divided into antibody development, antibody production and purification, antibody fragmentation and labeling. The source segment is divided into mice and rabbits. The application segment is divided into oncology, infectious diseases, immunology, neurobiology, stem cells, and cardiovascular diseases. The end-user segment is divided into pharma and biotechnology companies, hospitals and clinics, and contract research organizations. Based on regions, the market is further segmented into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. 

As per the regional analysis research, North America holds the largest market due to the advanced healthcare and research facilities available. In this region the government and biotechnology companies are focused on the advancements of drug design structure, research activities, improvement in the proteomics and genomics sector and increasing development in the therapeutics based on antibodies. The majority of the key players are also present in North America which is the major driving factor for enhancing the market. Asia-Pacific region also holds a significant market due to the improved infrastructure of the healthcare facilities, and better healthcare reimbursement policies. Moreover, the therapeutics industry is also growing in the regions of India and China which spurs the market growth.

                                  Custom Antibody Market Segmentation 




Monoclonal Antibodies,Polyclonal Antibodies,Recombinant Antibodies


Antibody Development,Antibody Production & Purification,Antibody Fragmentation & Labeling


Rabbit, Mice


Oncology, Infectious Disease, Immunology, Neurobiology, Stem Cells, Cardiovascular Disease

End user

Pharmaceutical and Biotechnology CompaniesHospitals and ClinicsContract Research Organizations


North America (U.S., Canada),Europe (Germany, France, Italy, Spain, UK),Asia Pacific (Japan, China, India, South Korea, Australia),Latin America (Mexico, Brazil, Argentina),Middle East & Africa (Saudi Arabia, South Africa, UAE)


Major companies operating in the custom antibody market include Thermo Fisher Scientific Inc., Merck KGaA, Cell Signaling Technology Inc., Rockland Immunochemicals, BioLegend, GenScript, Bio-Rad Laboratories Inc., Abcam PLC, Agilent Technologies, Innovagen Ab, ProMab Biotechnologies, Proteogenix, among others.

gvr icn


gvr icn

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

gvr icn


We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

Contact us now to get our best pricing.

esomar icon

ESOMAR certified & member

D&B icon

Leading SME award by D&B

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.

great place to work icon